| Literature DB >> 34035862 |
M C Maccarone1, G Magro1, U Solimene2, A Scanu3, S Masiero4.
Abstract
PURPOSE: The biologic mechanisms by which balneotherapy (BT) alleviates symptoms of different diseases are still poorly understood. Recently, preclinical models and clinical trials have been developed to study the effects of BT on the immune system. This review summarizes the currently available evidence regarding the effects of spa therapy on the immune response, to confirm the role of BT in the enhancement of immune system and open interesting research fields.Entities:
Keywords: Health resort therapy; Immune system; Mud therapy; Peloidotherapy; Spa therapy
Year: 2021 PMID: 34035862 PMCID: PMC8136372 DOI: 10.1007/s11332-021-00778-z
Source DB: PubMed Journal: Sport Sci Health ISSN: 1824-7490
In vitro studies on human samples evaluating the beneficial effects of BT on immune response in skin diseases
| Authors | Journal | Pathology | Experimental model | Treatment | Mineral water or inorganic or organic components | Biochemicalparameters | Results |
|---|---|---|---|---|---|---|---|
| Gobbi et al. 2009 [ | Lab Investig | Psoriasis | Normal skin-derived immortalized human keratinocytes | 30-min preincubation with MAPK/ERK inhibitors (10–30 μM) + NaHS (400 mM) dissolved in the culture medium, for 6, 12, 18, 24 h | NaHS | Cell proliferation and adhesion; MAPK/ERK signaling Phosphorylation | ↓keratinocyte cell growth and adhesion ↓MAPK/ERK phosphorylation ↓inflammation |
| Mirandola et al. 2011 [ | Lab Investig | Psoriasis | Normal skin-derived immortalized human keratinocytes | 30-min preincubation with MAPK/ERK inhibitors (10–30 μM) + NaHS (400 mM) dissolved in the culture medium, for 6, 12, 18, 24 h | NaHS | IL-8; MAPK/ERK signaling phosphorylation | ↓ basal and IL-17/IL-22-induced IL-8 expression and secretion ↓ MAPK/ERK phosphorylation ↓ inflammation |
| Chiarini et al. 2006 [ | Int J Mol Med | Psoriasis | Human primary epidermal keratinocytes | 25%, 50%, or 100% of Comano water dissolved in the culture medium, for 11 days | Comano spa’s water (Trentino, Italy), rich in sodium, calcium and bicarbonate | VEGF-A | ↓ VEGF-A ↓ VEGF-A-mediated effects |
| Chiarini et al. 2006 [ | Int J Mol Med | Psoriasis | Human primary epidermal keratinocytes | 25%, 50%, or 100% of Comano water dissolved in the culture medium, from 3 to 15 days | Comano spa’s water (Trentino, Italy), rich in sodium, calcium and bicarbonate | IL-6, CK-16, VEGF-A | ↓ IL-6, VEGF, and CK-16 release and expression ↓ inflammation, and neo-angiogenic phenomena |
| Dal Pra et al. 2007 [ | Int J Mol Med | Psoriasis | Human primary epidermal keratinocytes | 25%, 50%, or 100% of Comano water dissolved in the culture medium, from 11 to 13 days | Comano spa’s water (Trentino, Italy), rich in sodium, calcium and bicarbonate | IL-8, TNF-α | ↓ IL-8 and TNF-α ↓ inflammation |
| Karagülle et al. 2018 [ | Int J Biometeorol | Psoriasis and rosacea | Human keratinocyte cell lines | 10% of Bursa and Bolu thermal mineral waters dissolved in the culture medium, for 3 days | IL-1α, TNF-α, and VEGF | ↓ IL-1α, TNF-α, and VEGF gene expression ↓ inflammation, and neo-angiogenic phenomena | |
| Lee et al. 2012 [ | Ann Dermatol | Skin disease | Human keratinocyte cell lines | 50% of Yong-gung oncheon thermal spring water dissolved in the culture medium, for 1, 4, 10, and 24 h + LPS (10 μL/mL) | HaCaT Thermal spring water (Yong-gung oncheon, Ganghwa-gun, Korea), rich in sulfur, magnesium, calcium and selenium | IL-6, IL-8; CD4 + T cell differentiation | ↓ IL-6 and IL-8 gene and protein expression ↓ differentiation of CD4 + T cells in Th1, Th2 and Th17 ↓ immune skin reactions |
CK cytokeratin, ERK extracellular signal-regulated kinase, IL interleukin, LPS lipopolysaccharide, MAPK mitogen-activated protein kinase, NaHS sodium hydrosulfide, Th T helper, TNF tumor necrosis factor, VEGF vascular endothelial growth factor, ↓ decrease
In vitro studies on human samples evaluating the beneficial effects of BT on immune response in musculoskeletal diseases
| Authors | Journal | Pathology | Experimental model | Treatment | Mineral water or inorganic or organic components | Biochemicalparameters | Results | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fox et al. 2012 [ | J Cell Mol Med | RA | Human primary articular chondrocytes | IL-1β, IL-6 and TNF-α (5 ng/mL) for 6, 12 and 18 h + GYY4137 (50–500 mol/L) dissolved in the culture medium, for 12 h | GYY4137 | Cell death; Mitochondrial membrane potential | ↓ cell death and oxidant-induced mitochondrial dysfunction ↓ inflammation | ||||||||
| Li et al. 2013 [ | J Cell Mol Med | RA | Human primary arthritis synoviocytes and chondrocytes | (0.1–0.5 mM) dissolved in the culture medium, for 18 h + LPS (10 μg/mL) | GYY4137 | ↓ IL-6, TNF-α, PGE2 and NO production ↓ COX-2 and iNOS catalytic activity ↓ NF-kB activation ↓ inflammatory processes | |||||||||
| Burguera et al. 2014 [ | Osteoarthr Cartil | OA | Human primary OA chondrocytes | NaHS and GYY4137 (0.05–1 mM) dissolved in the culture medium, for 24 or 48 h + IL-1β (5 ng/mL) | NaHS and GYY4137 | IL-6, PGE2, PTGES, COX-2; NO, NOS2; MMP-13; NF-kB signaling activation | ↓ IL-6, PGE2, and NO release and protein level ↓ IL-6, PTGES, COX-2, and NOS2 gene expression ↓ NF-κB nuclear translocation ↓ inflammatory and degrading processes | ||||||||
| Ha et al. 2015 [ | Int J MolMed | OA | Human primary OA chondrocytes | NaHS (0.06–1.5 mM) dissolved in the culture medium, for 24 h + IL-1β (10 ng/mL) | NaHS | COX-2, iNOS, MMP-13; ERK/IκBα/NF-κB signaling activation | ↓ COX-2, iNOS, MMP-13 release and gene expression ↓ERK/IκBα/NF-κB activation ↓ degrading processes | ||||||||
| Sieghart et al. 2015 [ | J Cell Mol Med | Human primary OA fibroblast-like synoviocytes | NaHS (0.06–1 mmol/L) dissolved in the culture medium, for 1 h + IL-1β (10 ng/mL) | NaHS | IL-6, IL-8; MMP-2, MMP-14; MAPK and Akt1/2/PI3K protein phosphorylation | ↓ IL-6 and IL-8 secretion, MMP-2 and MMP-14 gene expression ↓ MAPK phosphorylation ↑ Akt1/2 phosphorylation ↓ inflammatory and degrading processes | |||||||||
| Vela-Anero et al. 2017 [ | Nitric Oxide | OA | Human OA cartilage disks | NaHS or GYY4137 (200 or 1000 μM) dissolved in the culture medium, for 21 days + IL-1β (5 ng/mL) | NaHS and GYY4137 | MMP-3, MMP-13; COL2A1, glycosaminoglycans, aggrecans | ↓ MMP-3 and MMP-13 production ↑ COL2A1, glycosaminoglycans and aggrecans synthesis ↓ degrading processes | ||||||||
| Fioravanti et al. 2013 [ | J Biol Regul Homeost Agents | OA | Human primary OA chondrocytes | 25%, 50%, or 100% of Vetriolo thermal water dissolved in the culture medium, for 48 h + IL-1β (5 ng/mL) | Vetriolo thermal water (Trentino Alto Adige Italy), strongly acidic sulfate, rich in calcium, magnesium and iron | NO, iNOS; Cell viability and apoptosis; Morphological assessment | 25%, 50% of Vetriolo water ↑ survival recovery rate ↓ NO levels, iNOS expressions, and apoptosis ↑ morphological characteristics ↓ degrading processes | ||||||||
| Kloesch et al. 2010 [ | Cell Biol Int | RA | fibroblast-like synoviocytes | NaHS (200 mM) | NaHS | IL-6; activation/deactivation of MAPKs; p38 and p44/42 MAPK (ERK1/2) | ↓ IL-1β-induced expression of IL-6 with low concentrations of NaHS H2S deactivates p44/42 MAPK (ERK1/2) ↑ activation of p38 MAPK, ERK1/2 and IL-6 with long-term exposure to H2S | ||||||||
| Kloesch et al. 2012 [ | Immunol Lett | RA and OA | RA and OA human fibroblast- like synoviocytes | NaHS (1.0 mM) dissolved in the culture medium, for 1, 3, 6, 12 h | NaHS | IL-6, IL-8, COX-2; MMP-2, MMP-3, MMP-14; p38/MAPK/ERK protein expression | ↑ IL-6, IL-8, COX-2 and p38/MAPK/ERK expression | ||||||||
| Kloesch et al. 2012 [ | Rheumatol Int | RA | Human chondrocyte cell line | NaHS (0.125 and 1.0 mM) dissolved in the culture medium, for 15, 30, 45 and 60 min + MAPK inhibitors (1 and 5 μM) + IL-1β(5 ng/mL) for 1 h | NaHS | IL-6, IL-8; P38/MAPK/ERK and NF-kB signaling activation/- deactivation | ↓ IL-6 and IL-8 ↓ p38/MAPK/ERK ↓ NF-kB signalling ↓ inflammatory processes | ||||||||
| Gambari et al. 2014 [ | Pharmacol Res | Osteoporosis | Human differentiated osteoclasts | NaHS (50–300 μM) dissolved in the culture medium, for 72 h to 6 days | NaHS | Osteoclasts differentiation; ROS production, NRF2, KEAP1, NQO1, and PRDX1 | ↓ osteoclast differentiation ↓ intracellular ROS levels ↑ NRF2 protein expression and nuclear translocation ↑ antioxidant gene | ||||||||
Akt protein-chinasi B, COL2A1 collagen type II alpha 1 chain, COX cyclooxygenase, ERK extracellular signal-regulated kinase, GYY4137 morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate, IκBα inhibitor of nuclear factor kappa B, IL interleukin, iNOS inducible nitric oxide synthase, KEAP1 kelch like ECH associated protein 1, LPS lipopolysaccharide, MAPK mitogen-activated protein kinase, MMP matrix metalloproteinase, NaHS sodium hydrosulfide, NF-kB nuclear factor kappa B, NO nitric oxide, NOS2 nitric oxide synthase 2, NQO1 NAD(P)H quinone dehydrogenase 1, NRF2 nuclear factor-erythroid factor 2-related factor 2, OA osteoarthritis, PGE2 prostaglandin E2, PI3K phosphoinositide 3-kinase, PRDX1 peroxiredoxin 1, PTGES prostaglandin E synthase, RA rheumatoid arthritis, ROS reactive oxygen species, TNF tumor necrosis factor, ↓ decrease, ↑ increase
In vitro studies on animal samples evaluating the beneficial effects of BT on immune response in musculoskeletal diseases
| Authors | Journal | Pathology | Experimental model | Treatment | Mineral water or inorganic or organic components | Biochemicalparameters | Results |
|---|---|---|---|---|---|---|---|
| Xu et al. 2011 [ | Free Radic Biol Med | Osteoporosis | Murine osteoblast-like cell line (MC3T3-E1) | NaHS (100 μM) dissolved in the culture medium, for 4 h + (H2O2) (400 μM) | NaHS | Viability, proliferation and apoptosis; NO, ALP, SOD, NADPH oxidase p38/ERK1/2/MAPKs activation | ↑ viability ↑ cell proliferation ↑ ALP and SOD activities ↓ apoptosis ↓ NO release ↓ NADPH oxidase activity ↓ p38/ ERK1/2/ MAPKs activation Proliferative and antioxidant effects against osteoporosis damage |
| Lv et al. 2017 [ | Am J Transl Res | Osteoporosis | Murine osteoblast-like cell line (MC3T3-E1) | GYY4137 (100 μM) dissolved in the culture medium, for 4 h + (H2O2) (400 μM) | GYY4137 | Viability, proliferation, Runx2, and apoptosis; NO, ALP, and SOD, ERK1/2 activation | ↑ viability ↑ cell proliferation ↑ ALP and SOD activities ↑ Runx2 gene expression ↓ apoptosis ↓ NO release ↓ ERK1/2 activation Proliferative and antioxidant effects |
| Liu et al. 2017 [ | Biochimie | Osteoporosis | Rat primary osteoblasts | NaHS (400 μmol/L) dissolved in the culture medium, for 12 h | NaHS | Osteoblast proliferation and mineralization; Apoptosis; KATP protein expression | ↓ cell proliferation ↑ apoptotic cells ↑ osteoblast mineralization ↑ KATP protein expression ↓ osteoporosis damage |
ALP alkaline phosphatase, ERK extracellular signal-regulated kinase, GYY4137 morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate, HO hydrogen peroxide, KATP ATP-sensitive potassium, MAPK mitogen-activated protein kinase, NADPH nicotinamide adenine dinucleotide phosphate, NaHS sodium hydrosulfide, NO nitric oxide, Runx2 runt-related transcription factor 2, SOD superoxide dismutase, ↓ decrease, ↑ increase
In vitro studies on human samples evaluating the beneficial effects of BT on immune response in inflammatory diseases
| Authors | Journal | Treatment | Experimental model | Mineral water or inorganic or organic components | Pathology | Biochemicalparameters | Results |
|---|---|---|---|---|---|---|---|
| Rinaldi et al. 2006 [ | Lab Investig | NaHS (from 0.23 to 3.66 mM) dissolved in the culture medium, for 24 h + p38/MAPK inhibitors (30–60 μM) | Human purified neutrophils, eosinophils or lymphocytes | NaHS | Inflammatory processes of respiratory tract | Cell viability and apoptosis; p38/MAPK signaling activation/deactivation | ↑ Short-term survival of neutrophils ↓ caspase-3 cleavage and p38/MAPK phosphorylation in neutrophils Accelerate the resolution of inflammatory processes |
| Mirandola et al. 2007 [ | J Cell Physiol | NaHS (from 0.20 to 4.0 mM) dissolved in the culture medium, for 24 h + caspase inhibitors (30 μM) | Human purified peripheral blood lymphocytes | NaHS | Inflammatory processes | Cell viability and apoptosis; IL-2 | ↓ proliferation of lymphocyte subsets ↓ D8 + T and NK cells ↓ IL-2 production Accelerate the resolution of inflammatory processes |
| Sulen et al. 2016 [ | Pharmacol Res | NaHS (10, 100 or 1000 μM) dissolved in the culture medium, for 10 min | Human peripheral blood mononuclear cells (PBMCs) | NaHS | Inflammatory processes | p38/MAPK, NF-κB p65, Akt and CREB phosphorylation | ↑ p38/MAPK, Akt, and CREB phosphorylation ↓ inflammatory processes |
| Han et al. 2013 [ | Cell Physiol Biochem | NaHS (0.25, 0.5, 1, 2, 4 and 8 mM) and GYY4137 (200, 400, 800, 1600 μM) dissolved in the culture medium, for 0.5, 1, 2, 4, 6, 12, 24, 36, 48 h | Human purified peripheral blood lymphocytes | NaHS and GYY4137 | Inflammatory processes of systemic lupus erythematosus | Cell viability, cell cycle distribution; Akt (ser473), GSK3β (ser9), p27Kip1 and p21CIP1 | ↑ cell proliferation and S phase distribution of cell cycle ↓ Akt (ser473), GSK (ser9) ↑ p27Kip1 and p21CIP1 expression and phosphorylation ↓ inflammatory processes |
| Braga et al. 2008 [ | Respiration | Sulfurous thermal water (different concentrations) dissolved in the culture medium, for 15 min + N-formyl-methionyl-leucyl-phenylalanine/phorbol-12-myristate-13-acetate | Human purified neutrophils | Sulfurous thermal water (Acqui Terme, Piemonte, Italy), which contains different HS groups concentrations | Inflammatory processes | ROS and RNS | ↓ ROS and RNS release at 0.94 to 15.5 μg/mL of HS ↓ inflammatoryprocesses |
| Braga et al. 2010 [ | TherAdvRespirDis | Sulfurous water or NaHS (from 4.5 to 18 mg/mL) dissolved in the culture medium, for 15 min | Human purified neutrophils | Sulfurous thermal water (AcquiTerme, Piemonte, Italy) and NaHS | Inflammatory processes of upper and lower airway diseases | Elastase release; elastolyticactivity | Inhibited elastase release ↓ inflammatory processes |
| Prandelli et al. 2013 [ | Int J ImmunopatholPharmacol | Sirmione thermal water or NaHS (2.5 mM) dissolved in the culture medium, for 24 h + LPS (100 ng/mL) | Human primary monocytes | Sirmione thermal water (Lombardia, Italy), rich in sodium chloride, bromine and iodine | Chronic inflammatory and age-related illness | TNF-α, IL-1β, IL-6, IL-12; CXCL8, CCL5; ROS, antioxidant enzymes | ↓ TNF-α, IL-1β, IL-6, IL-12, CXCL8, CCL5 production ↓ ROS formation and antioxidant enzymes Sirmione water ↑ IL-10 release ↓ chronic inflammatory and age-related illness manifestations |
| Vitale 2018 [ | Bol Soc Esp Hidrol Méd | Exogenous H2S on human resting CD4 T cell polarization to Th17 and/or Treg phenotype | Differentiated ex-vivo human resting CD4 + (Th0) T cells to Th17 or Treg lineages | NaHS | Immune-mediated pathologies | CD4 T cell polarization to Th17 and/or Treg phenotype | ↑ Foxp3 mRNA levels in CD4 + T cells cultured under Treg-polarizing conditions ↑ RORγT mRNA levels in CD4 + T cells under Th17 polarizing conditions |
AKT protein-chinasi B, CCL5 C–C motif chemokine ligand 5, CREB cAMP-response element-binding protein, CXCL8 C-X-C motif chemokine ligand 8, GSK3β glycogen synthase kinase 3 beta, HS sulfhydryl, IL interleukin, LPS lipopolysaccharide, MAPK mitogen-activated protein kinase, NaHS sodium hydrosulfide, NF-κB nuclear factor kappa B, NK natural killer, RNS reactive nitrogen species, ROS reactive oxygen species, Th T helper, TNF tumor necrosis factor, Treg regulatory T, ↓ decrease, ↑ increase
In vitro studies on animal samples evaluating the beneficial effects of BT on immune response in inflammatory diseases
| Authors | Journal | Treatment | Experimental model | Mineral water or inorganic or organic components | Pathology | Biochemicalparameters | Results |
|---|---|---|---|---|---|---|---|
| Miller et al. 2012 [ | J Biol Chem | H2S (50–500 nM) dissolved in the culture medium, for 4, 10, and 24 h | Primary mouse T lymphocytes (CD3 +), OT-II CD4 + T cells | H2S | Inflammatory processes of bowel diseases | CD69, CD25; IL-2; cystathionine γ-lyase, cystathionine β-synthase | ↑ T cell activation ↑ CD69 and IL-2 expression ↑ CD25 levels ↑ cystathionine γ-lyase and cystathionine β-synthase expression ↓ inflammatory processes |
HS hydrogen sulfide, IL interleukin, ↓ decrease, ↑ increase
RCTs and clinical trials evaluating the beneficial effects of BT on immune response
| First Author | Journal | N | Pathology | Age | Intervention | Treatment | Comparison | Type of water/inorganic or organic component | Systemic inflammatory Biomarkers | Stress biomarkers | Results |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bellometti et al. 1997 [ | Clinica Chimica Acta | 22 | OA | 63.6 year | Mud pack treatments | 12 applications of Mature thermal mud to the whole body for 20 min at 40 °C, followed by a bath for 10–12 min at 37–38 °C | Yes (22 control group only hot bath) | Mud of Abano-Montegrotto Terme | Serum IGF-1 and TNF-α | Differences between mean values found before and after the mud pack statistically significant | |
| Bellometti et al. 1998 [ | J Investig. Med | 31 | Healthy | Mud pack Therapy | PGE2 and LTB4 | ↓ PGE2 and LTB4 in serum | |||||
| Pascarelli et al. 2016 [ | IMAJ | 103 | OA | 68.49 ± 9.0 | Mud bath therapy | 2 weeks daily local mud-packs and baths | Control group ( | Water of the Chianciano Spa Resort (Siena, Italy) | COMP, CTX-II, MPO and hsCRP in serum | ↔ COMP, MPO and hsCRP in serum of either group ↑ in CTX-II serum levels in the mud-bath group after the treatment | |
| Ortega et al. 2017 [ | Int J Biometeorol | 21 | OA knee | 62–77 | Whole body Peloidotherapy | 1 session/die × 10 | No | SiO2, CaO, Al2O3 and Fe2O3 | IL-1β, TNF-α, IL-8, IL-6, TGF-β | SerumCortisol, eHsp72 | ↓ serum concentrations of IL-1β, TNF-α, IL-8, IL-6 and TGF-β ↑ systemic levels of cortisol ↓ circulating levels of eHsp72 |
| Galvéz et al. 2018 [ | International journal of hyperthermia | 36 | Knee OA | 70 | Whole-body mud therapy at 40–42 °C | 10-day cycle | No | SiO2, CaO, Al2O3 and Fe2O3 | IL-8, TGFb, CD4, CD 25, FOXP3, CD28, CD8, Neutrophils | ↓ circulating concentrations of IL-8 and TGF-β ↓ CD4 CD25 FOXP3 Treg cells ↑ CD8þ CD28– Treg cell ↑ neutrophils and phagocytic activity | |
| Tarner et al. 2009 [ | ClinicalRheumatology | 12 | AS | Meanage 33.4 years | Whole-body hyperthermia full bath | 9 cycles (initial water temperature of 36 °C that was increased gradually by 1 °C every 5 min to 40 °C. This temperature was maintained until the body temperature reached 38.5 °C) | Yes (12 healthy control) | nd | Serum levels of the cytokines TNF-α, IL-1B e IL-6 | ↓ TNF-α, IL-1β, and IL-6 ↔ 1 h after baseline, ↓6 h after baseline ↓At 24 h after the treatment | |
| Shehata et al. 2006 [ | The Middle European Journal of medicine | 83 | AS | 30–73 | Spa exercises therapy | 3–4 weeks spa-exercise therapy—in addition, outdoor exercises, physiotherapy, hydro-therapy and massage | Yes (control group with 10 patients with LBP and same treatment, second control group with 10 patients AS and no treatment) | Radon concentration up to 4.5 nCi/l; temperature 38–41 °C; relative humidity 70–98% | TGF-β1 | ↑ total and active TGF-β1 | |
| Ardic F. 2007 [ | Rheumatol Int | 12 | FibromyalgiaSyndrome | 43 | BT | Group 1 ( | Yes (9 group no treatment + 10 control group healthy women) | HCO3, SO4 | ESR, CRP, RF, PGE2, LTB4 and IL-1α in serum (before and at the end of general period of therapy) | ↓ serum PGE2 level ↓ IL-1 and LTB4 | |
| Eysteinsdóttir et al. 2013 [ | Scand JImmunol | 12 | Psoriasis | 36.7 | Bathing in geothermal seawater | Bathing in geothermal seawater twice daily for at least 1 h combined with NB-UVB therapy 5 days per week for 2 weeks | Yes (Of the 12 patients enrolled, six received treatment and 6 were treated with NB-UVB therapy) | Chemokines, inflammatory cytokines, T cells and TLRs in the blood and skin samples were evaluated on enrollment and at 1, 3 and 8 weeks | ↓ Th17 (IL-23R + CD4 + T cells) ↓ IL-23R expressed by these cells and their IL-17/IL-22 cytokine secretion ↓ Tc17 T cells (producing IL-17 and IL-22) after both of the treatments ↓ Th1 and Tc1 phenotype (IFN-c and TNF-α production) | ||
| Yamaoka et al. 2004 [ | J Radiat. Res | 15 | Healthy | 20–40 | A hot bathroom with a high concentration of radon | On days 1, 3, 5, 8, and 10, the inhalation of vapor from each hot spring under a condition of high humidity (about 90%) | Yes (3 groups: radon, thermal, and control.) | The temperature was 36 °C, the radon concentration was 2,080 Bq/m3 | C4 positive cells and CD8-positive cells | On days 5 and 10, ↑ CD4-positive cells ↓ CD8-positive cells in the radon group |
AlO aluminum oxide, CaO calcium oxide, AS ankylosing spondylitis, BT balneotherapy, COMP cartilage oligomeric matrix protein, CRP C-reactive protein, CTX-II C-terminal cross-linked telopeptide type II collagen, eHsp72 extracellular heat-shock protein 72, ESR erythrocyte sedimentation rate, FeO ferric oxide, FOXP3 forkhead box P3, HCO bicarbonate, hsCRP high-sensitivity C-reactive protein, IFN-c interferon-c, IGF-1 insulin-like growth factor 1, IL interleukin, LTB4 leukotriene B4, MPO myeloperoxidase, NB-UVB narrow-band ultraviolet B, OA osteoarthritis, PGE2 Prostaglandin E2, RF rheumatoid factor, SiO silicon dioxide, SO sulfate, TGF-β transforming growth factor beta, Th T helper, TLR toll-like receptor, TNF tumor necrosis factor, ↓ decrease, ↑ increase, ↔ no change